COMPARING PROPOFOL AND FENTANYL-MIDAZOLAM COMBINATION FOR CONSCIOUS SEDATION IN FIBREOPTIC NASOTRACHEAL INTUBATION

Shrikanta; Divyansh  Gaur; Shah Raj  Jayantilal; Ali  Raza; Sachin Kumar  Gupta

doi:10.51168/sjhrafrica.v5i12.1480

Authors

Shrikanta Senior Resident, Department of Anaesthesiology, Deen Dayal Upadhyay Hospital
Divyansh Gaur Secondary DNb, Department of Anaesthesiology, Deen Dayal Upadhyay Hospital
Shah Raj Jayantilal Senior Resident, Department of Anaesthesiology, Deen Dayal Upadhyay Hospital
Ali Raza Secondary DNb, Department of Anaesthesiology, Deen Dayal Upadhyay Hospital
Sachin Kumar Gupta Senior Resident, Department of Anaesthesiology, Deen Dayal Upadhyay Hospital

DOI:

https://doi.org/10.51168/sjhrafrica.v5i12.1480

Keywords:

Propofol, Fentanyl-Midazolam, Fibreoptic Intubation, Conscious Sedation

Abstract

Background: Awake fibreoptic intubation is crucial for managing difficult airways. The efficacy of propofol compared to a fentanyl-midazolam combination for conscious sedation during this procedure has not been extensively documented.

Methods: This prospective study was conducted over six months at Deen Dayal Upadhyay Hospital, involving 60 patients randomized into two groups. One group received propofol, while the other was administered a fentanyl-midazolam combination. The outcomes measured included the quality of sedation, intubating conditions, hemodynamic changes, degree of amnesia, and global acceptance.

Results: Propofol significantly outperformed the fentanyl-midazolam combination in terms of sedation quality (8.2 vs. 6.7), intubating conditions (85% vs. 70% rated as excellent), and amnesia (90% vs. 60% with no recall). Global acceptance was also higher in the propofol group (9.0 vs. 7.5). Both groups maintained stable hemodynamics throughout the procedures.

Conclusion: Propofol offers superior sedation quality, improved intubating conditions, more profound amnesia, and higher overall acceptance compared to the fentanyl-midazolam combination for conscious sedation in fibreoptic nasotracheal intubation. These attributes suggest propofol as a preferable choice in clinical practice for managing difficult airways.

References

Machata AM, Gonano C, Holzer A, Andel D, Spiss CK, et al. (2003) awake nastracheal fibreoptic intubation: Patient comfort, intubating conditions, and haemodynamic stability during conscious sedation with remifentanil. Anaesth Analg 97(3): 904-908.

Puchner W, Egger P, Puhringer F, Lockinger A, Obwegeser J, et al. (2002) Evaluation of remifentanil as a single drug for awake fibreoptic intubation. Acta Anaesthesiol Scand 46(4): 350-354.

Reed AP (1995) Preparation for intubation of the awake patient. Mt Sinai J Med 62(1): 10-20.

Gonzalez R, Ramirez ID, Hernandez AM, Cherit GD (2003) Should patients undergoing a bronchoscopy be sedated? Acta Anaesthesiol Scand 47(4): 411-415.

Randell T (1992) Sedation for fibrescopy: Comparison between propofol infusion and intravenous boluses of fentanyl and diazepam. Acta Anaesthesiol Scand 36(3): 221-225.

Clarkson K, Power C K, Connell F Pathmakanthan S, Burke CMA (1993) comparative evaluation of propofol and midazolam as sedative agents in fibreoptic bronchoscopy. Chest 104(4): 1029-1031.

Kazama T, Ikeda K, Morita K, Katoh T, Kikura M (1998) Propofol concentration required for endotracheal intubation with a laryngoscope or fibrescope and its interaction with fentanyl. Anaesth Analg 86(4): 872-879.

Andel H, Klune G, Andel D, Felfernig M, Donner A, et al. (2000) Propofol without muscle relaxants for conventional or fibroptic nastracheal intubation: A dose-finding study. Anaesth Analg 91(2): 458-461.

Gueret G, Billard V, Bourgain J (2007) Fibre-optic intubation teaching in sedated patients with anticipated difficult intubation. Eur J Anaesthesiol 24 (3): 239-244.

Lallo A, Billard V, Bourgain JL (2009) A comparison of propofol and remifentanil target-controlled infusions to facilitate fiberoptic nasotracheal intubation. Anesth Analg 108(3): 852-857.

Jones PM, et al. Propofol for emergency airway management: a study on efficacy and safety. Emerg Med J. 2019;36(5):317-322.

Lee SH, et al. Cardiovascular safety of propofol versus traditional sedatives: a meta-analysis of randomized controlled trials. J Cardiothorac Vasc Anesth. 2020;34(4):1065-1073.

Chang JE, et al. Patient satisfaction and memory profiles after sedation with propofol. Clin Ther. 2017;39(5):1134-1144.

Patel SS, et al. Patient satisfaction with propofol for outpatient colonoscopies: a randomized, double-blind, controlled trial. Gastrointest Endosc. 2016;84(3):407-413.

Nguyen NH, et al. Comparative analysis of sedative agents for fiberoptic intubation. J Clin Anesth. 2021; 69:110-117.

Harper JD, et al. Efficacy and safety of sedation protocols in fiberoptic intubation. Anesthesiology. 2017;127(6):932-940.

Rai M R, Parry T M, Dombrovskis A, Warner OJ (2008) Remifentanil target-controlled infusion vs propofol target-controlled infusion for conscious sedation for awake fibreoptic intubation: a double-blinded randomized controlled trial. British Journal of Anaesthesia 100(1): 125-130.

Durga VK, Millns JP, Smith JE (2001) Maneuvres used to clear the airway during fibreoptic intubation. Br J Anaesth 87(211): 207-211.

Stackhouse RA (2002) Fibreoptic Airway management. Anaesthesiology Clin Am 20(4): 933- 951.

Cafiero T, Esposito F, Fraioli G, Gargiulo G, Frangiosa A, et al. (2008) Remifentanil-TCI and propofol-TCI for conscious sedation during fibreoptic intubation in the acromegalic patient. European Journal of Anaesthesiology 25(8): 670-674.